Addex Gross Profit from 2010 to 2024

ADXN Stock  USD 15.55  3.19  17.02%   
Addex Therapeutics Gross Profit yearly trend continues to be very stable with very little volatility. Gross Profit is likely to grow to about -5.1 M this year. Gross Profit is the profit Addex Therapeutics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2012-09-30
Previous Quarter
-1.5 M
Current Value
-1.4 M
Quarterly Volatility
2.6 M
 
Yuan Drop
 
Covid
Check Addex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Addex main balance sheet or income statement drivers, such as Depreciation And Amortization of 290.7 K, Interest Expense of 20.5 K or Total Revenue of 2.8 M, as well as many exotic indicators such as Price To Sales Ratio of 223, Dividend Yield of 3.0E-4 or PTB Ratio of 346. Addex financial statements analysis is a perfect complement when working with Addex Therapeutics Valuation or Volatility modules.
  
This module can also supplement various Addex Therapeutics Technical models . Check out the analysis of Addex Therapeutics Correlation against competitors.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Latest Addex Therapeutics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Addex Therapeutics over the last few years. Gross profit is a required income statement account that reflects total revenue of Addex Therapeutics minus its cost of goods sold. It is profit before Addex Therapeutics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Addex Therapeutics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Addex Therapeutics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.44 M10 Years Trend
Pretty Stable
   Gross Profit   
       Timeline  

Addex Gross Profit Regression Statistics

Arithmetic Mean(3,593,992)
Geometric Mean0.00
Coefficient Of Variation(220.19)
Mean Deviation5,845,443
Median(407,586)
Standard Deviation7,913,653
Sample Variance62.6T
Range31.1M
R-Value(0.12)
Mean Square Error66.5T
R-Squared0.01
Significance0.68
Slope(206,308)
Total Sum of Squares876.8T

Addex Gross Profit History

2024-5.1 M
2023-5.3 M
2022-13.2 M
2021-9.9 M
2020-6.8 M
20192.5 M
20185.9 M

Other Fundumenentals of Addex Therapeutics

Addex Therapeutics Gross Profit component correlations

0.990.08-0.990.570.580.661.00.06-0.190.310.450.46-0.110.010.520.520.37
0.990.05-0.990.610.560.560.990.01-0.20.30.430.47-0.13-0.050.540.540.37
0.080.05-0.14-0.280.50.260.140.660.650.45-0.510.470.360.650.440.450.06
-0.99-0.99-0.14-0.53-0.6-0.61-1.0-0.090.11-0.36-0.36-0.550.06-0.04-0.6-0.6-0.37
0.570.61-0.28-0.530.140.070.53-0.41-0.66-0.170.59-0.25-0.63-0.51-0.15-0.150.39
0.580.560.5-0.60.140.470.610.690.310.460.030.520.330.590.520.520.16
0.660.560.26-0.610.070.470.630.36-0.030.270.370.20.110.410.210.220.17
1.00.990.14-1.00.530.610.630.1-0.110.360.370.54-0.060.050.590.590.37
0.060.010.66-0.09-0.410.690.360.10.580.37-0.360.370.690.960.290.3-0.18
-0.19-0.20.650.11-0.660.31-0.03-0.110.580.32-0.590.510.720.590.410.41-0.29
0.310.30.45-0.36-0.170.460.270.360.370.32-0.380.70.090.490.730.740.74
0.450.43-0.51-0.360.590.030.370.37-0.36-0.59-0.38-0.39-0.44-0.41-0.32-0.330.02
0.460.470.47-0.55-0.250.520.20.540.370.510.7-0.390.410.390.990.990.23
-0.11-0.130.360.06-0.630.330.11-0.060.690.720.09-0.440.410.690.270.27-0.53
0.01-0.050.65-0.04-0.510.590.410.050.960.590.49-0.410.390.690.320.33-0.07
0.520.540.44-0.6-0.150.520.210.590.290.410.73-0.320.990.270.321.00.34
0.520.540.45-0.6-0.150.520.220.590.30.410.74-0.330.990.270.331.00.35
0.370.370.06-0.370.390.160.170.37-0.18-0.290.740.020.23-0.53-0.070.340.35
Click cells to compare fundamentals

About Addex Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Addex Therapeutics income statement, its balance sheet, and the statement of cash flows. Addex Therapeutics investors use historical funamental indicators, such as Addex Therapeutics's Gross Profit, to determine how well the company is positioned to perform in the future. Although Addex Therapeutics investors may use each financial statement separately, they are all related. The changes in Addex Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Addex Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Addex Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Addex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Gross Profit-5.3 M-5.1 M
Gross Profit Margin(3.30)(3.46)

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

  0.69ELYM Eliem TherapeuticsPairCorr
  0.83ACB Aurora Cannabis TrendingPairCorr

Moving against Addex Stock

  0.85JNJ Johnson Johnson Aggressive PushPairCorr
  0.68GILD Gilead Sciences Earnings Call TodayPairCorr
  0.65PFE Pfizer Inc Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.
The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Addex Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Addex Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Addex Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Addex Therapeutics Stock:
Check out the analysis of Addex Therapeutics Correlation against competitors.
To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamental Analysis
View fundamental data based on most recent published financial statements
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
CEOs Directory
Screen CEOs from public companies around the world
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(18.44)
Revenue Per Share
2.64
Quarterly Revenue Growth
(0.69)
Return On Assets
(0.99)
Return On Equity
(3.48)
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.